Cellectis S.A. current report, Q2 FY2017

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on June 7, 2017. The filing serves to distribute a press release dated June 7, 2017, to U.S. investors. The registrant files annual reports under Form 20-F.

Financial Metrics

The provided filing text contains only the cover page and signature block of the Form 6-K. It does not include the attached press release or any financial statements. Consequently, the filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics.

Material Changes

As the specific content of the press release is not included in the input text, no material changes versus the prior comparable period can be identified from this document alone.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements would be contained within the referenced press release (Exhibit 99.1), which is not provided in the source text.

Key Facts for Investor Verification

  • The filing is a procedural Form 6-K referencing a press release dated June 7, 2017, which is not included in the provided text.
  • No financial data or operational updates are present in the cover page text.
  • Investors must locate and review the full text of the June 7, 2017 press release to understand the specific announcement made by the company.
  • The company is led by CEO André Choulika, who signed the report.